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Abstract 
An epidemic of den e 1 occurred in French Polynesia in December 1988 and June 1989. This paper rec- 
ords (i) the trend o g h e  outbreak and its surveillance and (ii) the clinical, epidemiological and virological 
data obtained from 1752 documented cases. The epidemic reached its peak in February in Tahiti Island, 7 
weeks after its recognition. Among 6034 suspect cases reported by sentinel physicians, 60.3% were <20 
years old. The illness was classical dengue. No fatality or case of dengue haemorrhagic feveddengue with 
shock syndrome was reported. Of 4792 patients subjected to laboratory testing, 41% were confirmed as 
positive. The serological attack rate was c. 40%. The estimated number of dengue infections in the Wind- 
ward Islands was about 20 000. Transmission was associated with Aedes aegvpti. Study of documented cases 
showed a higher confirmation rate in both the civilian population <I5 years old (46.5%) and the susceptible 
French military population (47.6%) than in older civilians (31.1%, P<0-05). Furthermore, primary dengue 
infections were predominant in both of the first 2 groups. The diagnosis was mostly confirmed (i) by virus 
isolation on day < 5  of illness and (ii) by detection of immunoglobulin (Ig) M on day 25 of illness. The 
study showed that adequate surveillance of an epidemic requires both clinically and laboratory-based sys- 
tems. 
Introduction 
French Polynesia is situated in the south Pacific ocean 
and consists of 5 archipelagoes (Society, Tuamotu, Gam- 
bier, Austral and Marquesas Islands), comprising 120 is- 
lands of which only 66 are inhabited. Most of the 
population is distributed in the Society archipelago 
which is subdivided into the Windward and Leeward Is- 
lands. Tahiti, the largest island of the Windward group, 
contains the capital, Papeete. The total population was 
188 814 in 1988: 145 O00 in Tahiti, of whom 79.1% live 
in the Papeete agglomeration. About 2300 inhabitants 
live in French Polynesia on a temporary basis. In all 
areas the climate is hot and tropical. A hot rainy season 
from November to April alternates with a cooler, drier 
season from May to October. The annual average 
temperature in Tahiti is 25-7°C. 
All 4 dengue virus serotypes have occurred in 
epidemic farm during the last 50 years in French Polyne- 
sia: dengue 1 in 1944 and 1975-1976, dengue 2 in 1971, 
dengue 3 in 1964 and 1969, and dengue 4 in 1979. From 
1979 to 1988, transmission of dengue 4 continued at a 
very low level (CHUNGUE~~ al., 1989b). 
In December 1988, dengue virus 1 was isolated from a 
15 years old child who presented with a dengue-like ill- 
ness. The patient lived in a suburb of Papeete. Sub- 
sequent survey showed that 2 family contacts possessed 
immunoglobulin (Ig) M anti-dengue antibodies. Based 
on the dates of the past dengue 1 epidemics (1944 and 
1975-1976), the susceptible population in the Windward 
Islands was estimated to be about 45 000, and consisted 
mostly of children born after 1979, some of those born in 
1977-1978, and people living on a temporary basis. Pre- 
vious serological study conducted in 1987 in Tahiti 
showed that 83.1%, 66.6%, 24.2% and 7.4% of children 
aged 15-19, 10-14, 5-9 and 0-4 years, respectively, had 
dengue antibodies for at least one serotype (CHUNGUE et 
al . ,  1989b). 
In this p,aper, we describe the trend of the epidemic 
and the various means of surveillance as well as clinical, 
epidemiological, virological and serological data obtained 
from 1752 clinical cases over the period December 1988 
to June 198'91. 
Materials and Methods 
Surveillance of the epidemic 
As soon as the outbreak was recognized, public health 
measures were instituted. Information messages were de- 
livered on vector control, on minimizing risk of infec- 
tion, and on the procedure to be adopted in the event of 
illness. Ultra-low volume (ULV) spraying of urban areas 
with malathion was started in the last week of 1988, and 
maintained until mid-March 1989. 
Weekly data were collected from December 1988 to 
June 1989, and overall indicators were available except 
for the number of declared suspect cases during weeks 
The surveillance of the epidemic involved the follow- 
ing operations. (i) Weekly reporting, by 25 sentinel 
physicians located throughout French Polynesia, of the 
number of clinically suspect cases, their age and their 
home address (a case of dengue was defined as a patient 
who presented with a sudden onset of febrile illness with 
any 2 of the 6ollowing symptoms: headache, myalgia, 
arthralgia, rash or haemorrhagic manifestations). (ii) Vi- 
rological and serological diagnosis (the weekly number of 
requests for laboratory testing and the weekly confirma- 
tion rate were measured). (iii) Estimation of the serologi- 
cal attack rate. Firstly, a cohort of 25 non-immune 
French soldiers, enrolled in August 1988 as part of our 
routine surveillance activity, had blood taken the day 
after their arrival, in December 1988 and February and 
April 1989. Clinical data and the presence of anti-dengue 
IgG andor IgM antibodies were recorded for each indi- 
vidual. Secondly, antibody prevalence in April 1989, in a 
random sample of children aged 0-9 years, was com- 
pared with that obtained in a similar sample and extrapo- 
lated back to a pre-epidemic value in December 1988 
(using an estimated annual antibody acquisition rate of 
2.95%; CHUNGUE et a l . ,  1989b). Thus, the attack rate 
was assumed to be equivalent to at least the difference 
between the seroprevalence rate observed before and 
after the epidemic. (iv) Virological survey investigations 
on mosquitoes collected in 5 sentinel stations, located in 
urban and semi-urban areas of Papeete. Detailed ento- 
mological studies will be presented elsewhere. 
Clinical specimens 
Blood samples were collected from 4792 patients with 
a clinical diagnosis of dengue. Sera were stored at -80°C 
for virus assays and at -2a"C for serological tests. Total 
leucocyte and platelet counts and haematocrit determina- 
tions were done using an automated counter (Coul- 
tronics, France). 
The group of documented cases referred to in this 
study consisted of 1752 patients from whom completed 
questionnaires containing demographic and clinical in- 
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Fig. 1. Weekly surveillance of dengue 1 epidemic according to different indicators. 
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Fig. 2. Weekly number of clinically suspect cases of dengue 1 reported by sentinel physicians, according to island group. 
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Fig. 3. Percentages of confirmation of dengue 1 diagnosis by virus isola- 
tion or detection of anti-dengue IgM antibodies according to day of illness 
(virus isolation was not attempted in 38 serum specimens collected after 
12 days of illness). 
Table 1. Distribution of clinically suspect cases of dengue reported by 
sentinel physicians by island group 
Island 
group 
No. of declared General Incidence 
cases population rate ( O h )  
Windward Is. 4483 140341 3.2 
Leeward Is. 1048 22232 47b  
Marquesas and Austral Is. 503 13967 3*6b 
Total 6034 175540" 3.4 
'Total population except Tuamotu and Gambier Is. 
bSigni6candy different from the Windward island incidence rate 
(PCO.01). 
Table 2. Estimation of serologically confirmed dlengue attack rate by 
comparison of dengue antibody prevalence in two sentinel groups 
before and after the epidemic 
Anti-dengue IgM andor Attack rate 
Susceptible population IgG prevalence (%) estimates (%) 
Cohort of dengue non-immune adults 
French soldiers (n=25) 
December 1988 0.00 
April 1989 44.00 44.00 
Children born 198&1985 
April 1987 (n=170) 11.76'' 
December 1988 (pre- 
epidemic estimated value) 16*67b 
April 1989. (n=lO9) 
(post-epidemic sample) 57.79 41.12 
PBaseliine data (CHUNGUE er al., 1989b). 
bEstimate calculated by extrapolation based on previous data that showed 
an anti-dengue antibody acquisition rate of 295% per year in children 
aged 2-7 years in April 1987 (CHUNGUE et al., 1989b). 
formations were obtained. The documented cases were 
subsequently grouped into civilian and military popda- 
tions (the latter including family members). 
Virus isolation 
Virus assays were attempted by inoculation of the first 
serum samples into clone C6/36 of Aedes albopictus cells 
using 24-well plates (Nunclon@, 2 cm2> and maintained 
in RPMI 1640 medium that contained 2% heat-inacti- 
vated foetal calf serum and antibiotics. Because of tox- 
icity to mosquito cells, samples diluted 1:40 in 200 pl of 
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Table 3. Frequency of clinical symptoms observed in 701 
laboratory-co-ed dengue patients 
Frequency 
Clinical symptoms ("/.I 
Fever/headache/myalgia 98.3 
Adenopathies 22.9 
Macular rash 20.9 
Digestive signs (vomiting, nausea, diarrhoea) 19.2 
Taste alterations 16.1 
Haemorrhagic signs (epistaxis, petechia, purpura) 5.1 
Hepatalgidhepatomegaly 5.0 
Pruritis/paresthesia 9.9 
Papular rash 4.7 
the maintenance medium were used. After incubation ait 
30°C for 7-10 d, the cells w'ere screened by an indirect 
fluorescent antibody test (IFAT) using dengue 2 hyper- 
immune ascitic fluid (American Type Culture Collec- 
tion) and fluorescein isothiocyanate-conjugated sheep 
anti-mouse IgG (Diagnostics Pasteur). Subsequent ident- 
ification was achieved by IFAT using serotype-specific 
monoclonal antibody (HENCHAL et al . ,  1983). 
Female adult A e .  aegypti and A e .  polynesim's were 
captured using the human bait collection technique 
(BONNET & CHAPMAN, 1958) and starved for 24-48 h 
before being killed by freezing. Pools of up to 50 mos- 
quitoes were constituted according to species and loca- 
tions. To each pool of mosquitoes were added 100 p1 
per mosquito of chilled phosphate-buffered saline 
(0.05 My pH 7.6) containing 20% heat-inactivated foetal 
calf serum and antibiotics. The material was then ground 
using an appropriately sized tissue grinder in an ice bath 
and centrifuged at SOOg for 20 min at 4°C. The clarified 
homogenate was processed similarly to serum specimens 
at a dilution 1: 10 in maintenance medium. 
Serological methods 
IgM capture enzyme-linked immunosorbent assay 
(ELISA). This was performed as previously described 
(CHUNGUE et al . ,  1989a), using 4 serotype antigens. For 
routine serodiagnosis of dengue fever, patients with an 
IgM reciprocal titre 2400 for any of the 4 antigens were 
considered as serologically conf i ied  cases. For serologi- 
cal surveys, all subjects with titres 3100 were considered 
positive since IgM may persist at a low level (<400) for 
90 d or msre after infection. 
IgG ELISA. The test was performed as previously de- 
scribed (CHUNGUE et al . ,  1989b). A reciprocal titre 2100 
for .%y of the 4 antigens tested was considered as IgG 
positwe. 
Haemagglutination-inhibition tests (HI)  and serological 
classifcation. The HI titres were determined by the 
method of CLARKE & CASALS (1958), using 4-8 haemag- 
glutinin units of dengue 1 and 2 viral antigens per test. A 
reciprocal titre <lo was considered as negative. 
Classification as primary or secondary infections was 
attempted in a random sample of 329 documented cases 
from whom virus had been isolated from acute serum. 
Thus, patients with a negative HI test for both dengue 1 
and 2 antigens in their acute serum were classified as pri- 
mary infections. Patients with a positive HI test for 
either antigen were tonsidered as having had a secondary 
infection. 
Statistical analysis 
tween proportions. 
Results 
Surveillance of the epidemic using different indicators 
The weekly number of (i) clinically suspect cases re- 
ported by sentinel physicians, (ii) patients subjected to 
laboratory conf ia t ion  by medical practitioners, 
whether sentinel or not, (iü) laboratory confimed cases, 
and (iv) the weekly laboratory conf ia t ion  rate, are 
The x2 test was used for analysis of differences be- 
Table 4. Numbers and percentages of cases c o n k e d  in the laboratory by age group in civilian and military 
populations among 1752 documented cases 
Study No. of confirmed casesaho. patients tested Significance All ages 
population c 1 5  years 2 1 5  years (P value) 
Civilian 
Males 167/347 (48.1%) 163/434 (37.1%) CO~001 330/781 (42.2%) 
Females 146/311 (46.9%) 92/374 (24.6%) <0*001 238/685 (34.7%) 
Total 313/658 (47.6%) 2551808 (31.6%) <0-001 568/1466 (38.7%) 
Males 10/20 (50.0%) 861179 (48.0%) >0*3 961199 (48.2%) 
Females 8/15 (53.3%) 29/72 (40.3%) >0*3 37/87 (42.5%) 
Total 18/35 (51.4%) 115/251 (45'8%) >Om3 133/286 (46.5%) 
Militaryb 
"Virologically and/or serologically confirmed. 
bIncluding family members. 
Table 5. Numbers and percentages of primary infections by 
age group in civilian and military populations from whom a 
positive diagnosis was obtained by virus isolation 
No. primary infectionslno. sera tested 
Age group Civilian population Military population" 
<IS years 91/120 (75.8%) 10112 (83.3%) 
3 1 5  years 66/119 (553%) 67/78 (85.8%) 
Total 1571239 (65.7%) 77/90 (855%) 
"Including family members. 
shown in Fig. 1. 
The weekly distribution of declared cases according to 
their geographical location is shown in Fig. 2. Table 1 
shows the incidence rates of declared cases by island 
group. Furthermore, amongst 6034 declared cases, 
60.3% were <20 years old. 
Overall, virological and/or serological positive results 
were obtained for 1966 of 4792 patients subjected to lab- 
oratory testing (41.1%). Confirmation was obtained by 
virus isolation for 1196 patients (24.9%) and by IgM cap- 
ture ELISA (in first serum or paired sera) for 770 patients 
(16.1%). Dengue 1 was the main serotype isolated since 
December 1988, May 1988 being the last time dengue 4 
was recovered. However, between mid-April 1989 and 
late June 1989, 5 cases of dengue type 3 were identified. 
Preliminary data on the dengue 3 epidemic which was 
later recognized in September 1989 have been reported 
elsewhere (CHUNGUE et al . ,  1990). 
Table 2 shows the results of the 2 methods of estimat- 
ing the attack rate during the epidemic. Thus, the com- 
bined results of IgM and IgG prevalence showed an 
attack rate of 44% at week 17 in the cohort of soldiers. 
Of 11 subjects who became positive for IgM and/or IgG 
antibody, 7 reported a febrile syndrome during the study 
period. The attack rate was at least 41.1%, estimated by 
calculating the difference between the serological pre- 
valence rate obtained in a random sample of susceptible 
children bled at the end of the epidemic (week 17) and 
that obtained in a similar sample before the epidemic. 
Dengue virus was isolated from 3 of 59 pools of A e .  
aegypti collected in sentinel stations (663 mosquitoes), 
and from none of 21 pools o f A e .  polynesiensis collected in 
the same areas (92 mosquitoes). In addition, all 4 pools 
of A e .  aegypti (74 mosquitoes) collected around the house 
of a confirmed case were positive. All isolates were 
dengue type 1 viruses. 
Study of I752 documented cases 
Dengue was confirmed virologically and/or serologi- 
cally in 701 documented cases (40%). The frequency of 
the various symptoms observed in these confirmed cases 
is presented in Table 3. Analysis of questionnaires 
showed that 75.9% of the patients consulted their physi- 
cian before day 4 of illness. No case fullfilling the World 
Health Organization criteria for dengue haemorrhagic 
feveridengue shock syndrome was reported. 
The distribution of documented cases by sex did not 
differ according to the age groups in either civilian or 
military populations (P>0.05, Table 4). Table 4 shows 
the age and sex distribution of the confirmed cases in 
both populations. Table 5 shows that 75.8% of civilian 
children <15 years old and 85.5% of the total military 
population were primary infections. 
The percentage of cases confirmed by virus isolation 
or detection of anti-dengue IgM antibodies among 701 
confirmed cases according to day of illness is shown in 
Fig. 3. Of 522 laboratory confirmations in patients who 
had blood taken before day 5 of illness, 90.6% were ob- 
tained by virus isolation, 8.2% by IgM detection, and 
11% by both methods. Conversely, on or after day 5 of 
illness, 19.5% were obtained by virus isolation, 77.1% by 
IgM detection and 3.3% by both methods. 
Total leucocyte and platelet counts were obtained for 
280 confirmed cases. Leucopenia (total leucocytes 
<4x10g/litre) was recorded in 62.5% of the confïmed 
cases (215 years). Thrombocytopenia (<150X 109/litre) 
was observed in 27.2% of the c o n f i e d  cases. 
Discussion 
Surveillance of the epidemic 
Dengue has occurred in French Polynesia as suc- 
cessive epidemics, especially between 1969 and 1979, 
with each epidemic involving a different serotype. Each 
time, the epidemic serotype replaced the unique endemic 
serotype that had been transmitted during the preceding 
inter-epidemic period. The reappearance of dengue 1 in 
late 1988 occurred while the endemic transmission of 
dengue 4 was very low. Although control efforts were in- 
itiated within a few days after its recognition, the 
epidemic developed explosively, according to all the in- 
dicators shown in Fig. 1. 
Fig. 2 shows that the epidemic moved from the Wind- 
ward Islands to the Leeward Islands and on to the Mar- 
quesas and Austral Islands. This observation is 
consistent with the fact that population movement by air 
is more intense between Tahiti and Leeward Island than 
between Tahiti and Marquesas or Austral Islands. Fur- 
thermore, the incidence rate of sentinel cases was higher 
in these remote islands (Table 1). At present, we cannot 
draw any conclusions from these results since (i) they 
might be due to varying degrees of survey coverage of 
the different populations, and (ii) bias in data collection 
certainly occurred: patient motivation for presentation, 
and the interpretation of case definition by sentinel 
physicians and their own enthusiasm for reporting, dif- 
fered in different areas. 
The age distribution of reported clinically suspect 
cases agreed with the preceding epidemiological back- 
ground that suggested higher susceptibility in children 
(CHUNGUE et a l . ,  1989b). Moreover, if the serological at- 
tack rates (41.1%-44?40) were applied to an estimated 
susceptible population of 45 000, the total serologically 
confirmed case incidence in the Windward Islands 
would be 18 495-18 980. Although declining thereafter, 
dengue 1 transmission continued until November 1990 
at a lower level (CHUNGUE et al . ,  1990). Since French 
Polynesia had experienced 2 extensive dengue 1 
epidemics in the past (ROSEN, 1958; KAUEFFER et a{ . ,  
1976), the proportion of the population infected with 
dengue 1 in late 1990 would be around 70%. Thus, the 
decline of epidemic transmission may be related to the 
increasing level of immunological coverage of the general 
population. Although community-based vector control 
has been maintained constantly, the impact of control ef- 
forts on the course of the epidemic is difficult to evaluate 
and will be discussed elsewhere (P. Barbazan, personal 
observations). Nevertheless, virus isolation from mos- 
quitoes provided evidence that dengue 1 was transmitted 
by Ae.  aegypti, which is widely distributed in French 
Polynesia. 
Ssudy of documented cases 
The proportion of confirmed cases was higher in both 
civilians <15 years old (46.5%) and in the overall mili- 
tary population (47.5%) when compared to that observed 
in civilians 3 1 5  years old (31.1%, P~0 .05) .  These re- 
sults confirmed the susceptibility to dengue infection of 
children bom after the previous dengue 1 epidemic 
(KAUEFFER et a l . ,  1976) and individuals living in French 
Polynesia on a temporary basis. Moreover, primary in- 
fections were predominant in children <I5 years old and 
in the total military population (Table 5). 
The proportion of confirmed cases among patients 
aged 15 years or more was higher in male civilians (Table 
4; P<O.OOI). That difference was not observed in the 
military population. We have not, so far, an adequate ex- 
planation for these observations. Work habits causing 
male civilians to be more exposed to mosquitoes might 
be related to the higher infection rate. Some authors 
have reported a predominance of men among dengue 
sufferers (LE GONIDEC et al . ,  1982; CHAN et a l . ,  1977; 
GUARD et al . ,  1984), while others have reported a higher 
frequency in females (GUZMAN et aZ., 1984). These dis- 
crepancies may have arisen because the population stu- 
died was not fully representative of the total susceptible 
population. 
Most of the patients consulted a physician during ahe 
febrile phase and had blood taken for laboratory confir- 
mation at that time. This observation emphasizes the im- 
portance of early diagnosis. Before day 5 of illness, the 
diagnosis was mostly confirmed by virus isolation. Con- 
versely, on or after day 5 it was usually confirmed by the 
detection of IgM (Fig. 3). The ov"H confimation rate 
was probably underestimated, as paired sera were not 
available for most of the cases and definitive confirma- 
tion could not be made, especially for those who had 
blood taken at day 4 or 5 of illness. Indeed, a higher iso- 
lation rate might be expected if serum samples had been 
used at a lower dilution. However, a 1:40 dilution rather 
than 1: 10 was preferred because of toxicity to mosquito 
cells (unpublished observations). Also, a higher confi- 
mation rate would be obtained if the cut-off titre for a 
positive result in the IgM capture ELISA were set at a re- 
ciprocal titre of 100 instead of 400. Nevertheless, our re- 
sults confirmed that virological and serological 
confirmatory methods are complementary in the light of 
the clinical history of patients; also leucopenia and 
thrombocytopenia were confirmed as good predictors of 
dengue diagnosis. The symptoms were typical of classi- 
cal dengue fever in the majority of cases. Only minor 
haemorrhagic manifestations were observed. 
The study of this epidemic indicated many of the diffi- 
culties in interpreting data collected by different means. 
Biases occurred in each system of surveillance and com- 
pliance of clinicians is difficult to maintain during a long 
period of time. Data may be influenced by incorrect in- 
itial diagnosis of other concurrently circulating viral dis- 
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eases, and clinically-based surveillance may result in over 
estimation (DIETZ et a¿., 1990). However, in our attempt 
to describe the epidemiological pattern and to monitor 
the surveillance of the epidemic, satisfactory results con- 
cerning time, age and geographical distributions were 
obtained. The weekly number of requests submitted for 
laboratory confirmation of diagnosis together with the 
level of the confimation rate appeared to be a good alter- 
native for estimating case distribution time trends. Fi- 
nally, this study emphasized the need for 
lab-oratory-based dengue surveillance systems to 
measure the real incidence of the disease. 
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